000 01410 a2200397 4500
005 20250517035357.0
264 0 _c20160418
008 201604s 0 0 eng d
022 _a1533-712X
024 7 _a10.1097/JCP.0000000000000356
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKoçer, Emel
245 0 0 _aDry Eye Related to Commonly Used New Antidepressants.
_h[electronic resource]
260 _bJournal of clinical psychopharmacology
_cAug 2015
300 _a411-3 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdrenergic Uptake Inhibitors
_xadverse effects
650 0 4 _aAdult
650 0 4 _aAntidepressive Agents
_xadverse effects
650 0 4 _aCase-Control Studies
650 0 4 _aCitalopram
_xadverse effects
650 0 4 _aDry Eye Syndromes
_xchemically induced
650 0 4 _aFemale
650 0 4 _aFollow-Up Studies
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aParoxetine
_xadverse effects
650 0 4 _aSelective Serotonin Reuptake Inhibitors
_xadverse effects
650 0 4 _aVenlafaxine Hydrochloride
_xadverse effects
700 1 _aKoçer, Abdulkadir
700 1 _aÖzsütçü, Mustafa
700 1 _aDursun, Ali Emre
700 1 _aKrpnar, İsmet
773 0 _tJournal of clinical psychopharmacology
_gvol. 35
_gno. 4
_gp. 411-3
856 4 0 _uhttps://doi.org/10.1097/JCP.0000000000000356
_zAvailable from publisher's website
999 _c24982943
_d24982943